-
Module 4_BCMA-Targeted Bispecifics
22:12
-
Module 4_Patient_Caregiver Education
17:09
-
Module 5: Experts Debate Optimal Selection and Sequencing Strategies_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MD, MSCE
21:45
-
Racial Differences in Clinical Trial Participation and Therapeutic Outcomes with a Focus on Multiple Myeloma_Craig Emmitt Cole, MD
51:36
-
Virtual Challenging Case Clinic: B-cell Lymphomas - Follicular Lymphoma_Loretta Nastoupil, MD
51:37
-
Virtual Challenging Case Clinic: B-Cell Lymphomas_Marginal Zone Lymphoma_Peter Martin, MD
51:30
-
Virtual Challenging Case Clinic: Multiple Myeloma_Updates from ASH_Peter Voorhees, MD
56:33
-
Virtual Challenging Case Clinic: Multiple Myleloma_Management of Early Relapse in the Evolving Treatment World_Krina Patel, MD, MSc
53:28
ABOUT
Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.
The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.
CONNECT
© Copyright 2021 Bio Ascend, a Vaniam Group company